GLP-1–based therapies refer to a class of medications known as glucagon-like peptide-1 receptor agonists. These therapies support weight loss by helping regulate appetite and improve metabolic function. Some well-known brand-name drugs belong to this class; however, Nuviva Medical Weight Loss does not promote or dispense brand-name medications.
All therapies used at Nuviva are prescribed under the supervision of a licensed medical provider and are sourced from FDA-registered pharmacies, when medically appropriate for each individyal. Your provider will evaluate your individual needs and determine whether a GLP-1–based treatment is appropriate for your weight loss plan.

GLP-1 based therapy is a medication used to treat type 2 diabetes. It belongs to the class of glucagon-like peptide-1 receptor agonists, which work by increasing insulin secretion and reducing appetite. Recently, a higher dose of GLP-1 based therapy has been approved by the FDA as a treatment for obesity, with the brand name Wegovy. It has been shown to be effective in aiding weight loss in overweight and obese individuals when combined with diet and exercise. GLP-1 weight loss medication works by suppressing appetite and reducing caloric intake, leading to sustained weight loss. However, it is important to note that it is not a magic pill and should only be used under the guidance of a Nuviva Coach.